Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q12846

Entry ID Method Resolution Chain Position Source
AF-Q12846-F1 Predicted AlphaFoldDB

231 variants for Q12846

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1177739426
CA395648834
3 D>E No ClinGen
gnomAD
CA395648828
rs1416796525
3 D>N No ClinGen
gnomAD
CA395648840
rs1193334181
4 R>K No ClinGen
gnomAD
TCGA novel 5 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA395648852
rs1241136551
6 H>D No ClinGen
gnomAD
rs1375705041
CA395648868
7 E>K No ClinGen
TOPMed
gnomAD
CA395648870
rs1375705041
7 E>Q No ClinGen
TOPMed
gnomAD
rs1405694324
CA395648889
8 L>P No ClinGen
TOPMed
rs1321458125
CA395648905
9 R>I No ClinGen
TOPMed
rs760104174
CA8018570
10 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs747824302
CA8018584
12 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA280563913
rs748093292
12 D>H No ClinGen
gnomAD
CA395648982
rs748093292
12 D>N No ClinGen
gnomAD
CA280563918
rs772128472
13 D>Y No ClinGen
TOPMed
gnomAD
CA395649024
rs1272164367
14 S>N No ClinGen
gnomAD
CA395649074
rs1596734089
17 E>K No ClinGen
Ensembl
rs1253154781
CA395649105
18 E>* No ClinGen
gnomAD
CA395649152
rs370946455
19 D>N No ClinGen
ESP
ExAC
gnomAD
CA8018587
rs370946455
19 D>Y No ClinGen
ESP
ExAC
gnomAD
CA280563932
rs931321219
20 K>N No ClinGen
TOPMed
gnomAD
rs1249546293
CA395649225
21 E>G No ClinGen
gnomAD
CA8018588
rs759958012
22 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA395649291
rs775695481
23 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs775695481
CA8018590
23 V>D No ClinGen
ExAC
TOPMed
gnomAD
CA395649336
rs1437011293
24 A>V No ClinGen
TOPMed
CA395649384
rs1596734152
26 V>G No ClinGen
Ensembl
CA395649412
rs1596734175
27 V>G No ClinGen
Ensembl
rs1347164142
CA395649406
27 V>L No ClinGen
TOPMed
CA395649425
rs1438830400
28 H>Y No ClinGen
gnomAD
CA8018592
rs764583237
29 P>A No ClinGen
ExAC
gnomAD
rs754062806
CA8018593
29 P>Q No ClinGen
ExAC
gnomAD
CA8018595
rs765337752
30 G>V No ClinGen
ExAC
gnomAD
CA8018597
rs369168805
31 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA395649590
rs1333479757
34 L>P No ClinGen
gnomAD
rs1596734250
CA395649669
36 S>G No ClinGen
Ensembl
rs1285892053
CA395649672
36 S>N No ClinGen
gnomAD
CA395649680
rs1596734255
36 S>R No ClinGen
Ensembl
rs754721884
CA8018600
37 P>L No ClinGen
ExAC
gnomAD
CA395649726
rs1596734267
38 D>G No ClinGen
Ensembl
CA8018603
rs747734355
39 E>* No ClinGen
ExAC
TOPMed
gnomAD
CA8018606
rs769504539
40 E>D No ClinGen
ExAC
TOPMed
CA280564022
rs1010575802
41 F>C No ClinGen
TOPMed
rs1189207190
CA395649810
41 F>L No ClinGen
gnomAD
CA395649802
rs1596734303
41 F>V No ClinGen
Ensembl
CA395649871
rs1459911429
44 K>M No ClinGen
gnomAD
CA280564117
rs990661615
45 V>I No ClinGen
TOPMed
rs770424224
CA8018627
46 R>Q No ClinGen
ExAC
gnomAD
rs184925516
CA8018626
46 R>W No ClinGen
1000Genomes
ExAC
CA8018628
rs778297706
47 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA395649954
rs1179466562
48 I>L No ClinGen
TOPMed
CA8018629
rs747451911
49 R>G No ClinGen
ExAC
gnomAD
rs777119919
CA8018632
52 I>F No ClinGen
ExAC
TOPMed
gnomAD
rs777119919
CA8018631
52 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA395650007
rs1454923298
56 G>A No ClinGen
TOPMed
gnomAD
rs1454923298
CA395650006
56 G>E No ClinGen
TOPMed
gnomAD
rs139470583
CA8018634
57 N>S No ClinGen
ESP
ExAC
TOPMed
rs1173257513
CA395650016
COSM1235783
58 K>E haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
gnomAD
rs984078860
CA280564156
58 K>R No ClinGen
TOPMed
CA280564161
rs908560895
60 Q>E No ClinGen
TOPMed
CA395650032
rs1432654416
60 Q>R No ClinGen
TOPMed
gnomAD
CA395650038
rs1567388221
61 E>G No ClinGen
Ensembl
CA8018635
rs763101653
61 E>K No ClinGen
ExAC
gnomAD
CA8018636
rs766416447
63 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1159653548
CA395650062
64 K>I No ClinGen
TOPMed
gnomAD
rs751659069
CA8018637
65 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA395650075
rs1399055544
66 Q>P No ClinGen
TOPMed
gnomAD
rs371627793
CA8018638
68 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1457381402
CA395650103
71 A>T No ClinGen
TOPMed
CA395650135
rs1161670402
76 E>* No ClinGen
TOPMed
rs930533328
CA395650137
76 E>G No ClinGen
gnomAD
rs930533328
CA280564254
76 E>V No ClinGen
gnomAD
CA395650149
rs1339376505
78 S>G No ClinGen
TOPMed
gnomAD
CA395650166
rs1289102779
78 S>R No ClinGen
gnomAD
CA395650148
rs1339376505
78 S>R No ClinGen
TOPMed
gnomAD
CA8018668
rs749918866
80 K>N No ClinGen
ExAC
gnomAD
CA8018667
rs764843164
80 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1216693053
CA395650240
88 D>G No ClinGen
gnomAD
rs1318817214
CA395650233
88 D>N No ClinGen
gnomAD
rs139153719
CA8018671
90 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8018672
rs756647558
92 Q>K No ClinGen
ExAC
gnomAD
rs778189453
CA8018673
94 G>E No ClinGen
ExAC
gnomAD
CA8018675
rs771153904
95 R>S No ClinGen
ExAC
gnomAD
CA395650347
rs1596734961
96 E>Q No ClinGen
Ensembl
CA8018676
rs374479299
97 I>V No ClinGen
ESP
ExAC
gnomAD
CA8018677
rs746110338
98 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs377624173
CA280564407
98 R>S No ClinGen
ESP
TOPMed
gnomAD
rs149926282
CA8018679
99 L>V No ClinGen
ESP
ExAC
gnomAD
CA395650508
rs1360730651
104 I>T No ClinGen
TOPMed
CA395650503
rs1216536490
104 I>V No ClinGen
TOPMed
CA395650513
rs1027422217
105 E>K No ClinGen
TOPMed
CA280564761
rs1027422217
105 E>Q No ClinGen
TOPMed
rs1567388717
CA621870445
105 E>V* No ClinGen
Ensembl
rs769649961
CA8018703
110 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA395650673
rs1195058329
111 A>G No ClinGen
gnomAD
rs1270976066
CA395650688
112 D>A No ClinGen
TOPMed
CA395650730
rs1324476752
114 N>K No ClinGen
TOPMed
rs140610940
CA280564780
118 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs140610940
CA8018705
118 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs751049136
CA8018707
123 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1398146678
CA395650939
124 K>R No ClinGen
TOPMed
gnomAD
CA8018709
rs192745083
125 T>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8018712
rs565521300
126 Q>* No ClinGen
1000Genomes
ExAC
gnomAD
rs1435482161
CA395651004
126 Q>H No ClinGen
gnomAD
CA8018740
rs748312857
127 H>L No ClinGen
ExAC
gnomAD
rs748312857
CA8018739
127 H>P No ClinGen
ExAC
gnomAD
rs1024123782
CA280566270
127 H>Y No ClinGen
TOPMed
CA395652818
rs1417180106
129 V>A No ClinGen
gnomAD
rs770790549
CA8018743
133 Q>H No ClinGen
ExAC
gnomAD
CA395652879
rs556202200
135 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA8018744
rs556202200
135 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs745502227
CA8018745
136 E>V No ClinGen
ExAC
TOPMed
gnomAD
rs1258834401
CA395652902
137 L>H No ClinGen
TOPMed
CA280566286
rs998256690
139 N>D No ClinGen
Ensembl
rs1358538375
CA395652921
COSM3690948
139 N>S large_intestine Variant assessed as Somatic; 4.619e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1416484319
CA395652927
140 K>Q No ClinGen
gnomAD
rs1313434688
CA395652947
141 C>* No ClinGen
gnomAD
rs144183945
CA8018746
144 M>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 145 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774836605
CA8018747
145 Q>K No ClinGen
ExAC
gnomAD
CA8018750
rs376363400
147 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1350520690
COSM185196
CA395653059
149 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA395653055
rs1284242148
149 R>W No ClinGen
gnomAD
rs1212161380
CA395653061
150 E>Q No ClinGen
gnomAD
CA280566310
rs766650870
152 N>K No ClinGen
ExAC
gnomAD
CA395653091
rs1440740574
152 N>S No ClinGen
gnomAD
CA8018753
rs752023820
153 V>M No ClinGen
ExAC
TOPMed
gnomAD
COSM1266993
CA8018755
rs767822435
155 R>Q oesophagus [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA8018754
rs755136571
COSM970073
155 R>W Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1419276118
CA395653140
157 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs141075935
CA8018756
157 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA395653211
rs1567390313
163 T>P No ClinGen
Ensembl
rs760980449
CA8018775
164 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1442076826
CA395653278
165 A>G No ClinGen
gnomAD
rs982538191
CA280566427
165 A>T No ClinGen
Ensembl
rs867510709
CA280566431
166 G>V No ClinGen
Ensembl
CA395653362
rs1329712277
172 E>A No ClinGen
gnomAD
CA280566451
rs1051195
174 E>D No ClinGen
Ensembl
CA395653418
rs1171957879
176 M>I No ClinGen
gnomAD
rs1230184420
CA395653446
179 S>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs754029888
CA8018777
182 S>N No ClinGen
ExAC
CA8018779
rs376829665
183 E>K No ClinGen
ESP
ExAC
gnomAD
rs750355371
CA8018780
184 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1167773750
CA395653534
185 F>S No ClinGen
TOPMed
CA395653553
rs1462285024
187 S>P No ClinGen
gnomAD
rs779834683
CA8018782
188 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs754597545
CA8018802
189 I>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 191 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs143510048
CA8018803
192 D>A No ClinGen
ESP
ExAC
gnomAD
TCGA novel 192 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8018804
rs150948517
193 T>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150948517
CA395653713
193 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 195 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8018808
rs141062694
197 R>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8018809
rs775974182
197 R>Q No ClinGen
ExAC
gnomAD
CA395653815
rs1319014234
199 A>D No ClinGen
gnomAD
rs1240907057
CA395653825
200 L>V No ClinGen
TOPMed
gnomAD
CA280566688
rs1001322275
202 E>D No ClinGen
TOPMed
gnomAD
CA395653901
rs1165344395
204 S>L No ClinGen
TOPMed
rs866878937
CA280566702
206 R>Q No ClinGen
Ensembl
rs769170826
CA8018811
206 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 208 S>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1259583499
CA395654025
212 Q>* No ClinGen
TOPMed
gnomAD
CA8018815
rs761952530
212 Q>H No ClinGen
ExAC
gnomAD
CA395654028
rs1259583499
212 Q>K No ClinGen
TOPMed
gnomAD
CA8018816
rs370196565
215 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs540497072
COSM1301903
CA8018817
215 R>H urinary_tract [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs540497072
CA395654129
215 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA395654143
rs1371068262
216 S>T No ClinGen
TOPMed
gnomAD
rs1462835263
CA395654187
COSM970074
218 R>C Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs373829816
COSM3361736
CA8018818
218 R>H kidney [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA395654223
rs1370002590
219 E>G No ClinGen
Ensembl
TCGA novel 221 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751532816
CA8018820
222 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs565199561
CA395654324
224 F>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs565199561
CA8018821
224 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA395654363
rs1360298642
225 T>S No ClinGen
gnomAD
CA395654389
rs945415027
227 L>V No ClinGen
gnomAD
rs1362993918
CA395654427
229 T>I No ClinGen
TOPMed
CA8018823
rs377468059
230 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA395654456
rs1375621480
231 V>A No ClinGen
gnomAD
TCGA novel 232 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs903964919
CA280566771
232 E>G No ClinGen
gnomAD
CA8018825
rs777322966
233 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs371244325
CA8018824
233 M>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1396756615
CA395654654
236 E>Q No ClinGen
TOPMed
CA8018852
rs200012136
237 M>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 237 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA280567386
rs532998208
238 I>M No ClinGen
Ensembl
TCGA novel 239 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs562489469
CA395654717
239 N>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs562489469
CA8018853
239 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs376701568
CA8018855
240 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8018854
rs770931989
240 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA395654806
rs1342351625
244 N>K No ClinGen
gnomAD
CA280567423
rs893251464
247 S>N No ClinGen
TOPMed
gnomAD
rs759458097
CA8018856
249 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs199709113
CA8018858
252 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA8018859
rs760346516
254 R>C No ClinGen
ExAC
gnomAD
CA280567439
rs200786971
254 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs200786971
CA8018861
254 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs200786971
CA8018860
254 R>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA280567452
rs966581561
257 E>D No ClinGen
TOPMed
rs1488866019
CA395655033
259 V>F No ClinGen
gnomAD
CA395655028
rs1488866019
259 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA280567460
rs1033941416
260 K>E No ClinGen
TOPMed
gnomAD
rs750008975
CA395655062
260 K>R No ClinGen
ExAC
gnomAD
rs750008975
CA8018864
260 K>T No ClinGen
ExAC
gnomAD
rs142253791
CA8018865
261 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1413409598
CA395655089
262 A>T No ClinGen
gnomAD
rs1162505941
CA395655128
264 E>G No ClinGen
gnomAD
rs376316073
CA280567507
COSM1478816
269 A>V Variant assessed as Somatic; 4.622e-05 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
NCI-TCGA
TOPMed
gnomAD
CA280567612
rs1037975946
272 K>N No ClinGen
Ensembl
CA8018885
rs753079913
274 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs138235448
CA8018886
279 C>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA395656334
rs1445294322
280 V>M No ClinGen
gnomAD
rs1378073962
CA395656390
282 I>N No ClinGen
gnomAD
CA8018887
rs764353518
282 I>V No ClinGen
ExAC
gnomAD
CA8018890
rs771745614
284 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA8018891
rs771745614
284 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA8018894
rs746913731
285 V>A No ClinGen
ExAC
gnomAD
CA8018892
rs149552887
285 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8018893
rs149552887
285 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs890878699
CA280567672
288 A>S No ClinGen
TOPMed
gnomAD
rs890878699
CA395656551
288 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1177838249
CA395656628
291 I>T No ClinGen
gnomAD
CA8018896
rs776543576
291 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA8018899
rs769736866
293 V>F No ClinGen
ExAC
TOPMed
gnomAD
COSM212242
CA8018898
rs769736866
293 V>I breast [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA8018900
rs762675311
295 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs1412304008
CA395656735
297 G>A No ClinGen
gnomAD
rs765803811
CA8018901
297 G>R No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with Q12846

No regional properties for Q12846

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q12846

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Single-pass type IV membrane protein
  • Cell projection, neuron projection
  • Localizes to neurite tips in neuronal cells
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

28 GO annotations of cellular component

Name Definition
basolateral plasma membrane The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
cell surface The external part of the cell wall and/or plasma membrane.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
dendritic spine A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
endomembrane system A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
endosome A vacuole to which materials ingested by endocytosis are delivered.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
lamellipodium A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments.
lateral loop Non-compact myelin located adjacent to the nodes of Ranvier in a myelin segment. These non-compact regions include cytoplasm from the cell responsible for synthesizing the myelin. Lateral loops are found in the paranodal region adjacent to the nodes of Ranvier, while Schmidt-Lantermann clefts are analogous structures found within the compact myelin internode.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
myelin sheath adaxonal region The region of the myelin sheath nearest to the axon.
neuron projection membrane The portion of the plasma membrane surrounding a neuron projection.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
phagocytic vesicle membrane The lipid bilayer surrounding a phagocytic vesicle.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
postsynapse The part of a synapse that is part of the post-synaptic cell.
presynaptic active zone membrane The membrane portion of the presynaptic active zone; it is the site where docking and fusion of synaptic vesicles occurs for the release of neurotransmitters.
SNARE complex A protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. One well-characterized example is the neuronal SNARE complex formed of synaptobrevin 2, syntaxin 1a, and SNAP-25.
somatodendritic compartment The region of a neuron that includes the cell body (cell soma) and dendrite(s), but excludes the axon.
specific granule Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.
storage vacuole A vacuole that functions primarily in the storage of materials, including nutrients, pigments, waste products, and small molecules.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
synaptic vesicle A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
trans-Golgi network The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
vacuole A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol.

3 GO annotations of molecular function

Name Definition
SNAP receptor activity Acting as a marker to identify a membrane and interacting selectively with one or more SNAREs on another membrane to mediate membrane fusion.
SNARE binding Binding to a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein.
sphingomyelin phosphodiesterase activator activity Increases the activity of the enzyme sphingomyelin phosphodiesterase.

24 GO annotations of biological process

Name Definition
cellular response to interferon-gamma Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
cellular response to oxidative stress Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
cornified envelope assembly The aggregation, arrangement and bonding together of a set of components to form a cornified envelope.
exocytosis A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
intracellular protein transport The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell.
long-term synaptic potentiation A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse.
organelle fusion The creation of a single organelle from two or more organelles.
positive regulation of catalytic activity Any process that activates or increases the activity of an enzyme.
positive regulation of cell adhesion Any process that activates or increases the frequency, rate or extent of cell adhesion.
positive regulation of cell migration Any process that activates or increases the frequency, rate or extent of cell migration.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of chemotaxis Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
positive regulation of eosinophil degranulation Any process that activates or increases the frequency, rate or extent of eosinophil degranulation.
positive regulation of immunoglobulin production Any process that activates or increases the frequency, rate, or extent of immunoglobulin production.
positive regulation of insulin secretion involved in cellular response to glucose stimulus Any process that increases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
positive regulation of protein localization to cell surface Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
positive regulation of protein localization to plasma membrane Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
protein localization to cell surface A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.
regulation of exocytosis Any process that modulates the frequency, rate or extent of exocytosis.
regulation of extrinsic apoptotic signaling pathway via death domain receptors Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
SNARE complex assembly The aggregation, arrangement and bonding together of a set of components to form a SNARE complex, a protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers.
synaptic vesicle fusion to presynaptic active zone membrane Fusion of the membrane of a synaptic vesicle with the presynaptic active zone membrane, thereby releasing its cargo neurotransmitters into the synaptic cleft.
vesicle docking The initial attachment of a transport vesicle membrane to the target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane. Docking requires only that the two membranes come close enough for these proteins to interact and adhere.
vesicle fusion Fusion of the membrane of a transport vesicle with its target membrane.

21 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32867 SSO1 Protein SSO1 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P39926 SSO2 Protein SSO2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P61267 STX1B Syntaxin-1B Bos taurus (Bovine) PR
Q3SWZ3 STX4 Syntaxin-4 Bos taurus (Bovine) PR
Q7KVY7 Syx4 Syntaxin-4 Drosophila melanogaster (Fruit fly) PR
Q24547 Syx1A Syntaxin-1A Drosophila melanogaster (Fruit fly) PR
P61266 STX1B Syntaxin-1B Homo sapiens (Human) PR
O75558 STX11 Syntaxin-11 Homo sapiens (Human) PR
Q16623 STX1A Syntaxin-1A Homo sapiens (Human) PR
O15400 STX7 Syntaxin-7 Homo sapiens (Human) PR
O35526 Stx1a Syntaxin-1A Mus musculus (Mouse) PR
Q00262 Stx2 Syntaxin-2 Mus musculus (Mouse) PR
Q9D3G5 Stx11 Syntaxin-11 Mus musculus (Mouse) PR
P61264 Stx1b Syntaxin-1B Mus musculus (Mouse) PR
P70452 Stx4 Syntaxin-4 Mus musculus (Mouse) PR
P50279 Stx2 Syntaxin-2 Rattus norvegicus (Rat) PR
P61265 Stx1b Syntaxin-1B Rattus norvegicus (Rat) PR
P32851 Stx1a Syntaxin-1A Rattus norvegicus (Rat) PR
Q08850 Stx4 Syntaxin-4 Rattus norvegicus (Rat) PR
O16000 unc-64 Syntaxin-1A homolog Caenorhabditis elegans PR
Q9ZPV9 SYP112 Syntaxin-112 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MRDRTHELRQ GDDSSDEEDK ERVALVVHPG TARLGSPDEE FFHKVRTIRQ TIVKLGNKVQ
70 80 90 100 110 120
ELEKQQVTIL ATPLPEESMK QELQNLRDEI KQLGREIRLQ LKAIEPQKEE ADENYNSVNT
130 140 150 160 170 180
RMRKTQHGVL SQQFVELINK CNSMQSEYRE KNVERIRRQL KITNAGMVSD EELEQMLDSG
190 200 210 220 230 240
QSEVFVSNIL KDTQVTRQAL NEISARHSEI QQLERSIREL HDIFTFLATE VEMQGEMINR
250 260 270 280 290
IEKNILSSAD YVERGQEHVK TALENQKKAR KKKVLIAICV SITVVLLAVI IGVTVVG